The patient you speak of had a stem cell transplant (unrelated to CHM) as part of their treatment. How can you suggest that their recovery is as a result of CHM’s treatment?
Ann: CORE NK Platform Phase 1 Clinical Data Presentation, page-35
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $20.55M | |||
| Open | High | Low | Value | Volume |
| 2.5¢ | 2.5¢ | 2.4¢ | $13.79K | 573.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 180644 | 2.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.5¢ | 847500 | 2 |
View Market Depth
| Last trade - 11.56am 14/05/2024 (20 minute delay) ? |
|
|||||
|
Last
2.4¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 2.4¢ | 2.4¢ | 2.4¢ | 17000 | ||
| Last updated 12.53pm 14/05/2024 ? | |||||
| CHM (ASX) Chart |